1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Has anyone left since the announcement?

Discussion in 'Allos Therapeutics' started by Anonymous, Apr 24, 2012 at 5:20 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Please let it be slumdog.
     
  2. Anonymous

    Anonymous Guest

    lkl;k;
     
  3. Anonymous

    Anonymous Guest

    Everyone is out of here. This place is poison. Management is looking. Hope none of these management end up any where I would be working!!!!!
     
  4. Anonymous

    Anonymous Guest

    Which Sr. Mgt is looking?
     
  5. Anonymous

    Anonymous Guest

    EBJS
     
  6. Anonymous

    Anonymous Guest

    Reject?
     
  7. Anonymous

    Anonymous Guest

    Looks like Caly rep has gone.
     
  8. Anonymous

    Anonymous Guest

    Any word on how slum dog doing?
     
  9. Anonymous

    Anonymous Guest

    Texas gone.
     
  10. Anonymous

    Anonymous Guest

    Florida gone
     
  11. Anonymous

    Anonymous Guest

    P or M?
     
  12. Anonymous

    Anonymous Guest

    Yep. Gone. Been real.
     
  13. Anonymous

    Anonymous Guest

    Is HQ still in the backroom office of Princeton, NJ or in Kalkutta, India?